申请人:DRIVINGFORCE THERAPEUTICS Co., Ltd.
公开号:US20180029979A1
公开(公告)日:2018-02-01
The present invention provides an isothiocyanate compound and its application. The compound is an aryl-substituted isothiocyanate compound that has a structure of the general formula I. The isothiocyanate compound of the present invention has very good solubility in water, far better inhibitory activity for XPO1 protein than other non-aryl substituted congeneric compounds, little side effects, and good biological safety and bioavailability, and is quite suitable for clinical application. Therefore, the isothiocyanate compound would have tremendous potential market space and economic benefits.
本发明提供了一种异硫氰酸酯化合物及其应用。该化合物是一种芳基取代的异硫氰酸酯化合物,其具有一般式I的结构。本发明的异硫氰酸酯化合物在水中具有非常好的溶解性,对XPO1蛋白的抑制活性远远优于其他非芳基取代的同源化合物,副作用小,具有良好的生物安全性和生物利用度,非常适合临床应用。因此,该异硫氰酸酯化合物具有巨大的潜在市场空间和经济效益。